Amniotic Membrane Market to Grow with a CAGR of 12.98% through 2029
Increasing Demand for Regenerative Medicine and increase in the aging
population is expected to drive the Global Amniotic Membrane Market growth in
the forecast period, 2025-2029
According to TechSci Research report, “Amniotic
Membrane Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2029”, the Global Amniotic Membrane Market
stood at USD 3.19 billion in 2023 and is anticipated to grow with a CAGR of 12.98%
in the forecast period, 2025-2029. The awareness among individuals regarding Amniotic
Membrane has led to favorable market conditions for the global Amniotic
Membrane market. Several factors contribute to the growth of various Amniotic
Membrane products. The awareness of bifurcation lesions and their
treatment options has been steadily increasing, both among healthcare
professionals and patients. Medical associations, educational programs, and
research efforts have contributed to a better understanding of the complexities
and challenges associated with bifurcation lesions. As healthcare professionals
become more proficient in diagnosing and treating these lesions, patient
outcomes improve, and the market for bifurcation lesion-specific products
expands.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Amniotic Membrane Market”
Patients and healthcare providers are increasingly
opting for minimally invasive procedures for the treatment of coronary artery
disease, including bifurcation lesions. These procedures involve smaller
incisions, shorter recovery times, and reduced risks compared to traditional
open-heart surgeries. The global trend towards minimally invasive interventions
in cardiology, such as percutaneous coronary intervention (PCI), has spurred
the demand for specialized tools and devices designed for bifurcation lesions,
which will further fuel market growth.
In August 2023, Applied Biologics LLC announces the
acquisition of Genetix Biotherapeutics, a leading provider of gene editing
technology. The acquisition expands Applied Biologics LLC's portfolio of
products and services and gives it access to Genetix Biotherapeutics' gene
editing technology, which can be used to develop new and innovative gene
therapies and cell therapies. Technological advancements in medical devices used for
the treatment of bifurcation lesions have been a significant driver of market
growth. These advancements include the development of specialized stents,
guidewires, and balloon catheters designed to treat bifurcation lesions with
greater precision and effectiveness. New materials, drug-eluting technologies,
and innovative designs have improved patient outcomes and reduced the risk of
complications, thereby driving the adoption of these devices.
In today's fast-paced world, Amniotic membrane
contains a rich array of growth factors, cytokines, and extracellular matrix
components that promote tissue repair and regeneration. It has been used in
wound care to accelerate the healing process, reduce scarring, and minimize
pain. In a world where accidents, injuries, and surgical procedures are common,
the application of amniotic membrane can lead to quicker recoveries and
improved outcomes. Amniotic membrane has demonstrated significant benefits in
ophthalmology. It is used in procedures to treat conditions like corneal
ulcers, burns, and conjunctivochalasis. The transparent and biocompatible
nature of amniotic membrane makes it an excellent choice for protecting and
repairing ocular surfaces. In a fast-paced world where eye health is paramount,
amniotic membrane can help individuals regain their vision and quality of life
more rapidly. In sports medicine and orthopedics, amniotic membrane is employed
to aid in the recovery of musculoskeletal injuries, such as tendonitis,
ligament injuries, and joint pain. The growth factors and anti-inflammatory
properties found in amniotic membrane can expedite the healing process,
allowing athletes and active individuals to return to their activities faster. Amniotic
membrane is used in dermatology for conditions like burns, chronic wounds, and
skin grafts. It can enhance the speed and quality of skin regeneration, helping
patients recover from various skin-related issues more quickly and with better
cosmetic outcomes. In dental and oral surgery, amniotic membrane is utilized
for tissue grafting and socket preservation following tooth extractions. The
growth factors and anti-inflammatory properties of amniotic membrane can
enhance healing and reduce post-operative complications, enabling patients to
recover more swiftly.
The rising prevalence of coronary artery disease (CAD)
worldwide. CAD is a leading cause of morbidity and mortality, and bifurcation
lesions are a common subset of this disease. As the incidence of CAD continues
to increase due to factors like sedentary lifestyles, unhealthy diets, and
aging populations, the demand for effective treatment options for bifurcation
lesions is also growing.
In recent times, Amniotic membrane has gained
significant traction in wound care and tissue repair. It is utilized for
chronic wounds, burns, surgical incisions, and diabetic ulcers. The amniotic
membrane's regenerative properties, including its ability to reduce
inflammation, promote cell proliferation, and modulate scar formation, make it
an effective tool for accelerating wound healing and minimizing complications. In
recent times, amniotic membrane has revolutionized ophthalmic treatments. It is
used in the management of corneal ulcers, chemical burns, and ocular surface
diseases. The transparent and biocompatible nature of amniotic membrane allows
it to serve as a natural bandage, protecting the cornea and promoting tissue
repair. This has led to improved outcomes and faster recoveries for patients
with eye-related conditions. In the field of orthopedics, amniotic membrane is
utilized to address a range of musculoskeletal conditions, including
tendonitis, ligament injuries, and osteoarthritis. Its anti-inflammatory
properties and growth factors aid in reducing pain and inflammation, while also
supporting tissue repair. Athletes and individuals with orthopedic injuries
benefit from the potential for quicker recovery and reduced downtime. However, Complexity
and Technical Expertise may hinder market growth. Moreover, challenges related
to Risk of Complications and Cost and Reimbursement Issues may pose obstacles
to the Amniotic Membrane market in the near future.
The Global Amniotic Membrane Market is segmented into product,
application, end-user, regional distribution, and company.
Based on its product, the Cryopreserved amniotic
membranes have an extended shelf life compared to their fresh or dehydrated
counterparts. Cryopreservation involves deep freezing the amniotic membrane,
which helps preserve its structural and biological integrity. This extended shelf
life ensures that healthcare providers have a readily available supply of
amniotic membrane products, reducing the risk of shortages and enabling
widespread adoption. Cryopreservation methods are designed to maintain the
biological activity of the amniotic membrane. This preservation of growth
factors, cytokines, and extracellular matrix components ensures that the
product retains its therapeutic efficacy when used in various medical
applications. The preserved biological activity is critical for achieving
consistent and positive patient outcomes.
Based on region, North America segment is expected to
grow during the forecast period. The robust healthcare
infrastructure and the presence of prominent industry leaders in North America
are the primary drivers of regional market growth. A heightened emphasis on
alternative technologies, coupled with the incorporation of advanced solutions,
is anticipated to propel market expansion in this area throughout the forecast
period.
The Europe market is poised to be the fastest-growing
market, offering lucrative growth opportunities for Amniotic Membrane players
during the forecast period. Factors such as the healthcare system in Europe is
publicly funded, and several countries have embraced universal healthcare,
leading to an increased demand for healthcare products. The growing number of
patients with chronic illnesses is projected to drive healthcare professionals'
adoption of amniotic membranes. According to the World Health Organization
(WHO), non-communicable diseases such as cardiovascular conditions, chronic
respiratory ailments, diabetes, and cancer collectively account for more than
86% of fatalities and 77% of the disease burden in Europe. Therefore, the high
prevalence of chronic diseases and an uptick in surgical procedures are
expected to expedite market growth.
Major companies operating in Global Amniotic
Membrane Market are:
- Alliqua BioMedical Inc.
- Amnio Technology, LLC
- Applied Biologics LLC
- Human Regenerative Technologies, LLC
- DermaSciences Inc
- Katena Products, Inc.
- MiMedx Group Inc.
- Skye Biologics, Inc.
- Amniox Medical Inc.
- Organogensis, Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The advancement in technology technology and Increasing
demand for regenerative medicine are key drivers of the Amniotic Membrane Amniotic
membrane is explored as an alternative to traditional pain management methods.
Its anti-inflammatory properties can alleviate pain associated with
musculoskeletal injuries, neuropathy, and chronic pain conditions. Moreover,
the growing consumer emphasis on preventative healthcare has enhanced
production and marketing efforts. To meet the demands of the market,
manufacturers are increasingly incorporating cutting-edge technologies with
high production efficiency. Rising consumer acceptance and continuous product
innovation will further ensure the growth of the Amniotic Membrane market in the coming years.,” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Amniotic Membrane Market – Global Industry
Size, Share, Trends, Opportunity, & Forecast 2019-2029 Segmented By Product
(Cryopreserved, Dehydrated), By Application (Surgical Wounds, Ophthalmology,
Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty
Clinics, Research And Academic Institutes), By Region, Competition”, has evaluated
the future growth potential of Global Amniotic Membrane Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Amniotic Membrane Market.
Contact
Techsci Research
LLC
420 Lexington
Avenue, Suite 300,
New York, United
States- 10170
Tel:
+13322586602
Email: [email protected]
Website: www.techsciresearch.com